MyD88 expressed by B cells has been shown to inhibit DSS-induced exacerbation of inflammatory bowel disease by secreting IgA and IgM in response to damaging intestinal microbiota dissemination (34). This evidence concerns the gene CD40LG and inflammatory bowel disease.